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Abstract 
Bacteriocins are proteinaceous toxins produced by bacteria to inhibit the growth of similar or closely 
related bacterial strains. Fermented Parkia biglobosa seeds (African locust bean) were screened for 
bacteriocin-producing lactic acid bacteria (LAB) with the characterization of putative bacteriocins. 
Bacteriocin-producing lactic acid bacteria (LAB) were identified by 16s rDNA sequencing. Molecular 
sizes of the bacteriocins were determined using the tricine-sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (tricine-SDS–PAGE) and effects of enzymes, pH, detergents and temperature on 
bacteriocin activity investigated, using standard procedures. Bacteriocins production and activities were 
measured by spectrophotometric analysis. Statistical analysis was carried out using student t-test and 
Analyses of Variance. Bacteriocigenic LAB isolated were Lactobacillus plantarum Z1116, Enterococcus 
faecium AU02 and Leuconostoc lactis PKT0003. They inhibited the growth of both Gram-positive and 
Gram-negative bacteria. The sizes of bacteriocins Z1116, AU02 and PKT0003 were 3.2 kDa, 10 kDa and 
10 kDa, respectively. The synergistic effects of characterized bacteriocins and rifampicin tested on 
organisms showed significant differences (P < 0.05), as compared with the effects of only one of the two. 
The antimicrobial activity of the three bacteriocins was deactivated after treatment of the cell-free 
supernatants with proteinase K, papain, pepsin and trypsin. Parkia biglobosa seeds are, therefore, rich in 
LAB bacteriocins which could be explored. The biosynthetic mechanisms of LAB bacteriocins could be 
employed in food safety and security, preservation, peptide design, infection control and 
pharmacotherapy. This should help in the control of undesirable bacteria and in designing more potent and 
selective antimicrobial peptides. 
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Introduction 
Fermented Parkia biglobosa seeds (Irú) is a type of fermented locust beans used as a condiment 
in cooking. It is similar to ogiri and douchi. It is very popular among the Yoruba people of 
Nigeria. It can be found fresh or dried. The fresh variety is usually wrapped in moimoi leaves, 
which are similar in appearance and texture to banana leaves. It has a pungent smell. The dried 
variety is flattened into discs or cakes for sale. Dried fermented Parkia biglobosa seeds (Irú) is 
weaker in flavor and pungency than fresh (though frying it in cooking oil will restore much of the 
flavor). The dried variety stores very well in freezers (Ogunshe et al., 2008).  
According to Campbell-Platt (1980), Iru or dawadawa (the most popular food condiment in 
the entire of savannah region of the West and Central Africa) are respective Yoruba and Hausa 
names for fermented seed cotyledons of African locust beans (Parkia biglobosa). It is an 
indigenous tree species that is economically and socially important for local people in sub-
Saharan Africa (Teklehaimanot, 2004).  
The fermentation of Parkia biglobosa seeds by Bacillus species is an example of an 
alkaline fermentation process (Achi, 2005), and after fermentation for 72-96 hours, the 
cotyledons become soft and dark with a strong characteristic ammoniacal odour (Odunfa, 1986; 
Achi, 1992). Furthermore, over-fermentation has been known to be capable of generating 
unacceptable levels of volatile fatty acids (Achi, 2005), while improper storage has also been 
known to cause maggot infestation and microbial contamination including antibiotic resistant 
bacteria. 
With the passage of time, non judicious use of antibiotics became common practice 
resulting in the reemerging infections. For solution, the derivatives of antibiotics were discovered 
and applied but pathogenic bacteria developed the resistance against them also. Now it was the 
need of time to search for new strategies for infection control of resistant pathogenic bacteria. 
Nowadays, consumers are aware of the health concerns regarding food additives; the health 
benefits of “natural” and “traditional” foods, processed without any addition of chemical 
preservatives, are becoming more attractive.   
Refocusing attention on food security is essential in the 21st century with a universal call to 
feed the hungry, and especially on the impact of biopatenting on poor communities who are the 
primary victims of hunger in our world. Antibacterial metabolites of lactic acid bacteria, such as 
bateriocins, have potential as natural preservatives to control the growth of spoilage and 
pathogenic bacteria in food. Bacteriocin is useful as a preservative in food due to its heat 
stability, wider pH tolerance and its proteolytic activity. Bacteriocins are ribosomally synthesized 
peptides originally defined as proteinaceous compound affecting growth or viability of closely 
related organisms (Gautam & Sharma, 2009; Bello et al., 2016a). 
The primary metabolite nature of bacteriocins is their most significant advantage over 
conventional antibiotics since they have relatively simple biosynthetic mechanisms compared 
with conventional antibiotics, which are secondary metabolites. This makes bacteriocins easily 
amenable through bioengineering to increase either their activity or specificity towards target 
microorganisms (Perez et al., 2014). The aim of this study was to partially purify and 
characterize bacteriocins from bacteria isolated from Parkia biglobosa seeds with the evaluation 
of their applications as antimicrobial agents. 





Materials and Methods  
Sources of Samples 
One hundred samples of fermented Parkia biglobosa seeds were purchased from local sellers in 
different markets which were Awolowo, Sagamu; Sabo, Sagamu; Falawo, Sagamu; Kuto, 
Abeokuta; Ago-Iwoye; Atikori, Ijebu-Igbo; Mamu, Ogun State; New market, Ijebu-Ode; Oke-
Aje; Ijebu-Ode; Tokin, Lagos; Sabo, Ikorodu; Igbogbo, Ikorodu; Ketu, Lagos; Oshodi, Lagos; 
Bariga, Lagos and Shomolu, Lagos. New Gbagi, Ibadan; Orita-challenge, Ibadan; Bodija, Ibadan; 
Agbeni-Ogunpa, Ibadan; Ojoo, Ibadan; Olodo, Ibadan; Aleshinloye, Ibadan; Iyana-Church, 
Ibadan; Iwo, Iwo.  
Assaying for bacteriocin-producing lactic acid bacteria 
Samples of Parkia biglobosa seeds were blended with electric blender (HR 28151, Netherland) 
and serial dilutions made and plated onto MRS agar (Biolab, Biolab Diagnostics, South Africa) 
supplemented with 50 mg/l Delvocid (Gist-brocades, B.V., Delft, The Netherlands). Colonies 
were covered with a second layer of MRS agar containing the same concentration of Delvocid. 
The plates were incubated anaerobically (OXOID, Gas Generation Kit, Hampshire, England) at 
30
O
C for 48 h. Plates with 50 or less colonies were covered with BHI medium containing 1.0% 
(m/v) agar (Merck, Darmstadt, Germany) and inoculated with Enterococcus faecium HKLHS 




). The plates were incubated for 24 h at 30
O
C. Colonies 
with inhibition zones were selected, cultured in MRS broth (Biolab) and tested for antimicrobial 
activity against E. faecium HKLHS and Lactobacillus sakei DSM 20017 by using the agar-spot 
test and disc diffusion methods (Todorov & Dicks, 2005a). The antimicrobial effect of lactic acid 
was eliminated by adjusting the pH of the supernatants to 6.0 with sterile 1 M NaOH. Activity 
was expressed as arbitrary units (AU) ml
-1
. One AU was defined as the reciprocal of the highest 
serial two fold dilution showing a clear zone of growth inhibition of the indicator strain (Bello et 
al., 2016a,b). 
Identification of isolates with antimicrobial activities 
Isolates with antimicrobial activity against L. sakei DSM 20017 and E. faecium HKLHS were 
selected and identified to genus-level according to their physiological and biochemical 
characteristics as described in a report by Bello et al. (2016a). Species-specific PCR included 
primers for Leuconostoc lactis (Llac F: 5-AGG CGG CTT ACT GGA CAA C-3 and Llac-R: 5-
CTT AGA CGG CTC CTT CCA T-3; Lee et al., 2000), Lactobacillus plantarum (plan F: 5-
CCG TTT ATG CGG AAC ACC TA-3 and REV: 5-TCG GGA TTA CCA AAC ATC AC-3; 
Torriani et al., 2001), and genus-specific primers for Enterococcus spp (Ent1: 5-TAC TGA CAA 
ACC ATT CAT GAT G-3 and 5-AAC TTC GTC ACC AAC GCG GAA C-3; Ke et al., 1999). 
The universal primers 8f (5-CAC GGA TCC AGA CTT TGA TYM TGG CTC AG-3) and 
1512r (5-GTG AAG CTT ACG GYT AGC TTG TTA CGA CTT), where Y indicates C + T and 
M indicates A + C, were used to amplify the 16S rDNA gene according to Felske et al. (1997). 
Amplified fragments with the correct sizes were cloned into pGEM
∞
-T Easy Vector 
(pGEM∞-T Easy Vector Systems, Promega, Madison, USA) and transformed to E. coli  DH5α. 
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Transformed cell suspensions (100 µl) were plated onto Luria Bertani agar (Biolab), 
supplemented with ampicillin (100 µgml
-1
), X-gal and IPTG. After 12 h of incubation at 37
0
C, 
transformants were selected and plasmid DNA was isolated using the QIAprep Spin Miniprep Kit 
(Qiagen∞, Valencia, California, USA). DNA was sequenced using the bigdye™ terminator cycle 
chemistry (Biosystems, Warrington, England) on an ABI Genetic Analyzer 3130XL Sequencer 
(Applied Biosystem, SA, Pty, Ltd.) (Felske et al., 1997; Bello et al., 2016b). 
Bacteriocin production 
MRS broth (Biolab) was inoculated with a 24-h-old culture (2%, v/v) of a bacteriocin-producing 
strain (each of Lactobacillus plantarum Z1116, Enterococcus faecium AU02 and Leuconostoc 
lactis PKT0003). Incubation was at 30
O
C. Antimicrobial activity (AU ml
-1
) of the bacteriocins, 
and changes in pH and optical density (at OD600 nm) of the cultures, were determined at 3 h and 1 




) was used as sensitive strain. In addition, 
forty-five bacterial strains were used in the determination of spectra of activity. They were 




C, respectively (Torriani et al., 2001). 
Molecular size of the bacteriocins 
Young actively growing cultures were centrifuged for 15 min at 10,000g and the pH was 
corrected to 6.0 with 6 M NaOH. To prevent proteolytic degradation of the bacteriocins, cell-free 
supernatants were treated for 10 min at 80
O
C. Ammonium sulfate was added slowly to the cell-
free supernatants to 60% saturation for Lactobacillus plantarum Z1116, Enterococcus faecium 
AU02 and Leuconostoc lactis PKT0003, stirred for 4 h at 4
O
C and then centrifuged (10,000g, 1 h, 
4
O
C). The precipitates were re-suspended in 10 ml 25 mM ammonium acetate buffer (pH 6.5) 
and desalted by dialysis (1000 Da cut-off dialysis membrane, Spectrum Inc., CA, USA). Further 
separation was by tricine–SDS–PAGE, as described by Schägger and Von Jagow (1987). A low 
molecular weight marker with sizes ranging from 2.5 to 45.0 kDa (Amersham Biosciences 
Europe GmbH, Freiberg, Germany) was used. The gels were fixed and one half stained with 
Coomassie Blue R250 (Saarchem, Krugersdorp, South Africa). The position of the active 
bacteriocin was determined in the unstained gel, as described by Bello et al. (2016b). E. faecium 




), suspended in MRS broth (Biolab) supplemented 
with 1% (m/v) agar, was used as a sensitive strain. 
Effects of enzymes, pH, detergents and temperature on bacteriocin activity 
Cell-free supernatants of bacteriocin-producing strains, obtained by centrifugation (8000g, 10 
min, 4
O
C), were adjusted to pH 6.0 with 1 M NaOH. Two mils of samples were incubated for 2 h 
in the presence of 1.0 or 0.1 mg ml
-1
 (final concentration) trypsin (Roche, USA), pronase 
(Roche), Proteinase K (Roche), pepsin (Roche), papain (Roche) and α-amylase (Roche) and then 
tested for antimicrobial activity using the agar-spot test method. In a separate experiment, the 
effect of sodium dodecyl sulphate (SDS), Tween 20, Tween 80, urea, Triton X-100, Triton X-114 
and Na–EDTA on bacteriocins in cell-free supernatants was determined as described by Todorov 
and Dicks (2006a). The effect of pH on the bacteriocins was determined by adjusting the cell-free 
supernatant from pH 2.0 to 12.0 at intervals of half, with sterile 1 M HCl or 1 M NaOH. After 2 h 
of incubation at 30
O
C, the samples were readjusted to pH 6.5 with sterile 1 M HCl or 1 M NaOH 
and the activity was determined as described before (Bello et al., 2016a, 2016b). The effect of 















C, respectively. Residual bacteriocin activity was tested after 30, 60 and 120 min at 
each of these temperatures, as described before (Todorov et al., 2006). 
Response of isolates to bacteriocins 
A 10 ml aliquot of bacteriocin-containing filter-sterilized (0.20 µm, Minisart∞, Sartorius, USA) 
supernatant (pH 6.0) was added to a 100 ml culture of L. sakei DSM 20017 or E. faecium 
HKLHS in an early exponential phase (OD600 = 0.12) and incubated for 15 h. Optical density 
readings (at 600 nm) were recorded at 1-h intervals. In a separate experiment, extracellular levels 
of β-galactosidase activity were monitored. Eleven-h-old cultures of E. faecium HKLHS and L. 
sakei DSM 20017 (80 ml each) were harvested and the cells were washed twice with 0.03 M 
sodium phosphate buffer (pH 6.5) and re-suspended in 16 ml of the same buffer. Two millilitres 
of each cell suspension were treated with 2 ml of bacteriocins Z1116, AU02 and PKT0003 
respectively, for 5 min at 25
0
C, followed by the addition of 0.2 ml 0.1 M ONPG (O-nitrophenyl-
β-D-galactopyranoside, Fluka, USA) in 0.03 M sodium phosphate buffer (pH 6.8). After 10 min 
at 37
O
C, the reaction of β-galactosidase was stopped by the addition of 2.0 ml 0.1 M sodium 
carbonate. The cells were harvested (8000g, 15 min, 25
0
C) and the absorbance readings of the 
supernatant were recorded at 420 nm. Cells disrupted with 0.1 mm diameter glass beads vortexed 
(for 5 min) served as control (Todorov et al., 2006). 
Adsorption study of the bacteriocin to the producer cells 
This was studied according to the method described by Yang et al. (1992). After 18 h of growth 
at 30
O
C, the culture was adjusted to pH 6.0, the cells were harvested (10,000g, 15 min, 4
O
C) and 
washed with sterile 0.1 M phosphate buffer (pH 6.5). The cells were re-suspended in 10 ml 100 
mM NaCl (pH 2.0), stirred for 1 h at 4
O
C and then harvested (12,000g, 15 min, 4
O
C). The cell-
free supernatant was neutralized to pH 7.0 with sterile 1 M NaOH and tested for activity as 
previously described. The percentage adsorption of bacteriocins to the target cells was calculated 
according to the following formula: 
% adsorption = 100 – (bacteriocin activity after treatment   x 100) (Vaucher et al., 2011) 
      original bacteriocin activity 
 
Statistical analysis of data obtained 
Paired-Samples T-test and One-way Analysis of Variance (ANOVA) were used to determine the 
statistical difference between the microbial activity of bacteriocins and antibiotic (rifampicin) 
against L. monocytogens NCTC 4885 using SPSS version 17.0.   
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Results  
Table 1 shows the lactic acid bacterial genera isolated from Parkia biglobosa. Bacteriocigenic 
LAB strains were Lactobacillus plantarum Z1116, Enterococcus faecium AU02 and Leuconostoc 




Table 1. Bacterial genera isolated from protein-rich foods from Parkia biglobosa  
Bacteriocigenic LAB Other LABs 
Lactobacillus plantarum Z1116,  
Enterococcus faecium AU02  
Leuconostoc lactis PKT0003 
Lactobacillus plantarum,  
L. fermentum  
L. pentosus 
 
Table 2 shows the spectra of activities of L. plantarum Z1116, E. faecium AU02 and L. 
lactis PKT0003 against certain Gram-positive and Gram-negative bacterial strains. Out of 45 
indicator bacterial strains investigated for their sensitivity to the different bacteriocin-like 
inhibitory substances, 27 (60%) were sensitive (positive) to Z1116, 25 (55.56%) were positive to 
AU02 and 15 (33.33%) sensitive to PKT0003.   
Table 2. Antibacterial spectrum of activity of bacteriocins produced by L. plantarum Z1116, E. 
faecium AU02 and L. lactis PKT0003 against bacterial indicator strains 
 






Z1116 AU02 PKT0003 
Enterococcus 
faecalis 1071  
MRS
g


















E. faecalis E88  MRS 30 - + 
E. faecalis E90  MRS 30 - + 
E. faecalis E92  MRS 30 - + 
E. faecalis ET05
a
  MRS 30 + + 
E. faecalis ET12
a 
 MRS 30 + - 
E. faecalis ET88
a
  MRS 30 + - 
E.faecium HKLHS  MRS 30 + + 










 37 + + 
E. coli  P46  BHI 37 - - 
E. coli  P8  BHI 37 - - 
Klebsiella 
pneumoniae P30  
BHI 37 + + 














L. casei Shirota  MRS 30 - - 
L. curvatus DF38  MRS 30 + - 
L. curvatus ET34
a 
 MRS 30 - - 
L. curvatus ET06
a 
 MRS 30 - - 
L.delbruekii ET32
a
  MRS 30 + - 
L. jonhsonii Lc1  MRS 30 + + 
L.jonhsonii 
VPI1830  
MRS 30 + - 
L.plantarum 
ST202Ch  
MRS 30 + - 
L. rhamnosus Lgg  MRS 30 + + 




MRS 30 - + 
L. salivarius 241 
MRS 




MRS 37 - - -  









BHI 37 + + + 
L. monocytogenes 
ScottA  





BHI 37 + + - 
P. aeruginosa P22  BHI 37 - - + 
P. aeruginosa P7  BHI 37 + + - 
Pseudomonas  spp 
P28  
BHI 37 + + + 
S. aureus P13  BHI 37 + + - 
S. aureus P36  BHI 37 + - + 
S. aureus P37  BHI 37 - - - 





BHI 37 + - + 
Streptococcus   
agalactiae  P9  
BHI 37 - - - 




Bacteriocin-like inhibitory activity  
   Z1116 AU02 PKT0003 
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Streptococcus   




BHI 37 - + - 




BHI 37 - + - 
Streptococcus   
faecalis P20  
BHI 37 + + + 
Streptococcus   spp 
TL2R  
BHI 30 - + - 
Keys: – = No activity; + = inhibition zone. 
a
 Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Porto, Portugal. 
b
 ATCC: American Type Culture Collection, Manassas, VA, USA. 
c
 DSM: Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, 
Braunschweig, Germany. 
d
 LMG: Laboratorium voor Microbiologie, Universiteit Gent, Gent, Belgium. 
e
 NCTC: National Collection of Food Bacteria, Reading, UK. 
f
 UWC: Department of Microbiology, University of Western Cape, Cape Town, South 
Africa.  
g
 De Man, Rogosa and Sharpe. 
h
 Brain Heart Infusion. 
All other strains were from Department of Biological Sciences, Faculty of Science and 
Technology, North-West University, Mafikeng, South Africa. 
 
 
Figure 1: Agarose gels showing DNA fragments obtained after PCR with species-specific 
and genus-specific primers. Lanes 1 and 2: strain Z1116, lanes 3 and 4: L. plantarum NCBF 363, 
lane 5: no DNA loaded, lane M1: O’GeneRuler™ 100-bp DNA Ladder from Fermentas, lanes 6 
and 7: strain AU02, lane 8: E. faecalis PTA-7278 (ST4SA), lane 9: no DNA loaded, lane M2: 




O’GeneRuler™ Ultra Low Range DNA Ladder from Fermentas, lane 10: strain PKT0003, lane 
11: L. lactis NCDO 533 (DSM 20202T), lane 12: no DNA loaded and lane M3: O’GeneRuler™ 
1 kb DNA Ladder (Fermentas).  
 
Figure 1 shows agarose gels of DNA fragments obtained after PCR with species-specific 
and genus-specific primers. Strain Z1116 did not produce gas from glucose but fermented 
carbohydrates and this is typical of L. plantarum. DNA amplification yielded a fragment identical 
in size to that reported for L. plantarum. Strain AU02 does not produce gas from glucose, 
ferments the same sugars as E. faecium, and produces an amplicon characteristic for the genus 
Enterococcus. Strains PKT0003 produced gas from the fermentation of glucose, display 
carbohydrate fermentation profiles similar to that of Leuconostoc species. 
 
Figure 2. Growth of L. plantarum Z1116 in MRS broth in association with bacteriocin production 
at different cell densities. 
Figure 2 shows the growth of L. plantarum Z1116 in MRS broth in association with 
bacteriocin production at different cell densities. This established the activities of bacteriocin 
Z1116 (500 AU ml
-1
) at the 9
th
 hour and which progresses gradually till the highest level of 
activity (12,000 AU ml
-1
) was attained at the 18
th
 hour of growth in MRS broth (30
O
C). This 
remained at this level of activity for the duration of fermentation which elapsed at the 24
th
 hour. 
This high level of activity of bacteriocins occurred at a high cell density (6.8 OD600 nm) at the 
18
th
 hour of fermentation.  
Natural and Engineering Sciences                       81 
                                                                                         
 
 
   
 
Figure 3. Growth of E. faecium AU02 in MRS broth in association with bacteriocin production at 
different cell densities. 
Figure 3 shows the growth of E. faecium AU02 in MRS broth in association with 
bacteriocin activity at varying cell densities. The highest level of bacteriocin AU02 activity 
(3,200 AU ml
-1
) was recorded at the 21
st
 hour of growth and this was followed by stable 
production for remaining 3 hours of fermentation process. The cell density was highest (2.8 
OD600 nm) at 21
st




Figure 4. Growth of Leuconostoc lactis PKT0003 in MRS broth in association with bacteriocin 
production at different cell densities. 
Figure 4 shows the growth of Leuconostoc lactis PKT0003 in MRS broth in association 
with bacteriocin production at different cell densities. Growth was monitored and recorded and 
was found that bacteriocin production picked up at the 9
th
 hour (200 AU ml
-1
) and progresses 




over the next 15 hours where the highest level of activity (1600 AU ml
-1
) was recorded at the 24
th
 
hour. At this period of fermentation, cell density measured 2.75 OD600 nm.  
 
 
Figure 5: Tricine-SDS–PAGE of bacteriocins Z1116, AU02 and PKT0003. Lanes 1, 4 and 7: 
molecular mass marker (2.5–45.0 kDa, Amersham). Lanes 2, 5 and 8: peptide bands stained with 
Coomassie Blue R250. Lanes 3, 6 and 9: zones of growth inhibition corresponding to the position 
of bacteriocins Z1116, AU02 and PKT0003, respectively. The gel was overlaid with E. faecium 
HKLHS and L. sakei DSM 20017, respectively (ca. 1 x 10
6
 CFU/ml) suspended in BHI and MRS 
agar. The sizes of bacteriocins Z1116, AU02 and PKT0003, as revealed by tricine-SDS–PAGE, 
were 3.2 kDa, 10 kDa and 10 kDa, respectively. 
 
Table 3 shows the factors affecting the antimicrobial activity of bacteriocins Z1116, AU02 
and PKT0003. Cell-free supernants of bacteriocins Z1116, AU02 and PKT0003 were subjected 
to treatments with some enzymes, surfactants, EDTA and varying pH and temperature values. 
The antimicrobial activity of the three bacteriocins was deactivated after treatment of the cell-free 
supernatants with proteinase K, papain, pepsin and trypsin. No change in activity levels was 
recorded when the cell-free supernatants of strains Z1116 and AU02 were treated with α-amylase 
and catalase. Treatment of the cell-free supernatant containing bacteriocin PKT0003 with α-
amylase resulted in loss of antibacterial activity. All three bacteriocins remained active after 
incubation at pH 2.0–8.0. Treatment at pH 12.0 resulted in the loss of activity for strains AU02 
and PKT0003. No decrease in antimicrobial activity was recorded after treatment of the cell-free 
supernatants at 25, 30, 37, 45 and 60
0
C for 60 and 120 min.  
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Table 3: Factors affecting the antimicrobial activity of bacteriocins Z1116, AU02 and PKT0003 







Enzymes (1.0 or 0.1 mg/ml)    
α-Amylase + + - 
Catalase + + + 
Proteinase K, papain, pepsin, trypsin - - - 
Surfactants (1% final concentration)    
SDS, Tween 20, Tween 80, urea, Triton X-100  + + + 
Triton X-114 - - + 
Protease inhibitor (1.0, 2.0, 5.0 mm)    
Na-EDTA + + + 
Ph    
2.0-8.0 + + + 
10.0 + - + 
12.0 + - - 
Temperature (
0
C) (1 h):    
25, 30, 37, 45, 60  + + + 
100 + + + 
Temperature (
0
C) (2 h):    
25, 30, 37, 45, 60  + + + 
100 + + - 
Temperature (
0
C) (120 mins):    
121  + + - 
Keys:  - = activities affected;  + = activities not affected 
 
Figures 6 and 7 show the effects of bacteriocins produced by A) Lactobacillus plantarum 
strain Z1116, B) Enterococcus faecium AU02 and C) Leuconostoc lactis PKT0003 on the growth 
of E. faecium HKLHS and L. sakei DSM 20017, respectively. The modes of activity of these 
bacteriocins were bactericidal against E. faecium HKLHS and L. sakei DSM 20017. Inhibition of 
growth of test organism was observed at the introduction of only the clinical antibiotic 
(rifampicin) at final concentration of 0.2 µg ml
-1
 but this was not statistically significant (P > 
0.05). Rifampicin at final concentrations of 0.1 µg ml
-1
 and 0.05 µg ml
-1
 showed very weak 
inhibition of growth, and thus, not statistically significant as compared with the control 
experiment. It was interesting to establish the synergistic effects of rifampicin and these 
bacteriocins on L. monocytogenes NCTC 4885. Rifampicin at final concentration of 0.2 µg ml
-1
 
and bacteriocin Z1116 at concentration of 160 AU ml
-1
 exerted bactericidal effect on the test 
organism while this synergistic effect was also well established at lower concentrations of the 









Figure 6: Effect of bacteriocin produced by A) Lactobacillus plantarum strain Z1116, B) 
Enterococcus faecium AU02 and C) Leuconostoc lactis PKT0003 on the growth of E. faecium 
HKLS. 
 
Figure 7: Effect of bacteriocin produced by A) Lactobacillus plantarum strain Z1116, B) 
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Figure 8: Effect of bacteriocin Z1116 and antibiotic (rifampicin) on the growth of L. 
monocytogenes NCTC 4885. 
Control = no bacteriocin or rifampicin added to BHI with corrected to 7.0; R 0.2 = rifampicin at 
final concentration of 0.2µg ml
-1
; R 0.1=rifampicin at final concentration of 0.1 µg ml
-1
; R 
0.05=rifampicin at final concentrationof 0.05 µg ml-1; B 160 = bacteriocin Z1116 at 
concentration of 160 AU ml
-1
; B 80=bacteriocin Z1116 at concentration of 80 AU ml
-1
; B 
40=bacteriocin Z1116 at concentration of 40 AU ml
-1





Figure 9 shows the effect of bacteriocin AU02 and antibiotic (rifampicin) on the growth of 
L. monocytogenes NCTC 4885. Bacteriocin AU02 showed weaker antibacterial activity against 
L. monocytogenes NCTC 4885 as compared with bacteriocin Z1116. Bacteriocin AU02 at 
concentration of 160 AU ml
-1 
exerted visible antibacterial effect, though not statistically 
significant (P > 0.05). Also, inhibitions of growth exerted by rifampicin at all concentrations 
were not significantly different from the control (P > 0.05). There was, however, notable 




synergistic effect of this bacteriocin on the test organism when combined with different 
concentrations of the antibiotic. This difference was statistically significant (P < 0.05).  
 
 
Figure 9: Effect of bacteriocin AU02 and antibiotic (rifampicin) on the growth of L. 
monocytogenes NCTC 4885. 
 
Control = no bacteriocin or rifampicin added to BHI with corrected to 7.0; R 0.2 = 
rifampicin at final concentration of 0.2ug ml-1; R 0.1=rifampicin at final concentration of 0.1 ug 
ml-1; R 0.05=rifampicin at final concentrationof 0.05 ug ml-1; B 160 = bacteriocin AU02 at 
concentration of 160 AU ml-1; B 80=bacteriocin AU02 at concentration of 80 AU ml-1; B 
40=bacteriocin AU02 at concentration of 40 AU ml-1; B 16=bacteriocin AU02 at concentration 
16 AU ml-1 
 
Figure 10 shows the effect of bacteriocin PKT0003 and antibiotic (rifampicin) on the 
growth of L. monocytogenes NCTC 4885. Just like bacteriocins Z1116 and AU02, bacteriocin 
PKT0003 exerted stronger antibacterial effect on the test organism than the sub-lethal 
concentrations of rifampicin investigated in this study. Bacteriocin PKT0003 at concentration of 
160 AU ml
-1 
exerted visible antibacterial effect against L. monocytogenes NCTC 4885 and this 
was statistically significant (P < 0.05) as compared with control experiment. The synergistic 
relationship of bacteriocin PKT0003 and rifampicin at their different concentrations was also 
well established as they were able to exert stronger antimicrobial effects on the test. 
Natural and Engineering Sciences                       87 
                                                                                         
 
 
   
 
 
Figure 10: Effect of bacteriocin PKT0003 and antibiotic (rifampicin) on the growth of L. 
monocytogenes NCTC 4885 
 
Control = no bacteriocin or rifampicin added to BHI with corrected to 7.0; R 0.2 = rifampicin at 
final concentration of 0.2µg ml
-1
; R 0.1=rifampicin at final concentration of 0.1 µg ml
-1
; R 
0.05=rifampicin at final concentrationof 0.05 µg ml
-1
; B 160 = bacteriocin PKT0003  at 
concentration of 160 AU ml
-1
; B 80=bacteriocin PKT0003  at concentration of 80 AU ml
-1
; B 
40=bacteriocin PKT0003  at concentration of 40 AU ml
-1
; B 16=bacteriocin PKT0003  at 





Table 4 shows the extracellular levels of β-galactosidase (absorbance detected at 420 nm) 
recorded after treatment of E. faecium HKLHS and L. sakei DSM 20017 with bacteriocins 
Z1116, AU02 and PKT0003. The results obtained about the leakage of DNA, RNA, proteins and 
β-galactosidase confirmed that bacteriocins Z1116, AU02 and PKT0003 were able to destabilize 
the permeability of the cell membrane.  
  




Table 4: The extracellular levels of β-galactosidase (absorbance detected at 420 nm) recorded 
after treatment of E. faecium HKLHS and L. sakei DSM 20017 with bacteriocins Z1116, AU02 
and PKT0003 
(A) Intact cells of E. 
faecium HKLHS 
Partially broken cells of 
E. faecium HKLHS 
Bacteriocin E. faecium 
HKLHS treated 
with bacteriocin 
Z1116 0.023 0.172 0.014 0.259 
AU02 0.023 0.172 0.090 0.112 
PKT0003 0.023 0.172 0.012 0.203 
(B) Intact cells of L. 
sakei DSM 20017 
Partially broken cells of 
L. sakei DSM 20017 
Bacteriocin L. sakei DSM 
20017 treated 
with bacteriocin 
Z1116 0.020 0.168 0.090 0.212 
AU02 0.020 0.168 0.017 0.176 
PKT0003 0.020 0.168 0.007 0.181 
 
Table 5 shows the percentage adsorption of bacteriocins Z1116, AU02 and PKT0003 to 
cells of E. faecium HKLHS and L. sakei DSM 20017. Incubation of the producer cells in the 
presence of 100 mM NaCl at pH 2.0 did not result into liberation of activity of bacteriocins AU02 
and PKT0003, suggesting that these three bacteriocins do not adsorb to cell-surfaces of the 
producer cells. For bacteriocins Z1116, activity was observed after treatment with 100 mM NaCl 
at pH 2.0 which suggests the ability of the bacteriocin to adsorb to the cell-surface of the 
producer cells. 
Table 5: Adsorption of bacteriocins Z1116, AU02 and PKT0003 to cells of E. faecium 
HKLHS and L. sakei DSM 20017 
Bacteriocins E. faecium 
HKLHS 
% Adsorption L. sakei 
DSM 20017 
% Adsorption 
Z1116 + 90% + 90% 
AU02 - 20% - 30% 




In this study, bacteriocigenic LAB strains isolated were Lactobacillus plantarum Z1116, 
Enterococcus faecium AU02 and Leuconostoc lactis PKT0003 and other LAB isolates were 
Lactobacillus plantarum, L. fermentum and L. pentosus. The bacteriocins inhibited the growth of 
E. faecalis HKLHS, Listeria innocua LMG 13568, Listeria ivanovii subsp. Ivanovii ATCC 
19119, E. coli P40, Klebsiella pneumoniae P30 and Pseudomonas sp. P28. Todorov and Dicks 
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(2006a) reported similar activity against some Gram-negative bacteria for bacteriocins ST242BZ, 
ST284BZ, ST414BZ, ST461BZ and ST712BZ produced by L. paracasei ST242BZ and 
ST284BZ, L. plantarum  ST414BZ, L. rhamnosus ST461BZ and L. pentosus ST712BZ. More 
recently, studies on some Afican food condiments showed that Leuconostoc lactis T196 from 
Colocynthis cintrullus (Bello et al., 2016a) and Leuconostoc lactis DZ2 from Irvingia. 
gabonensis (Bello et al., 2016b) exerted antibacterial activities against both Gram-positive and 
Gram-negative bacterial strains. 
Strain Z1116 did not produce gas from glucose and fermented carbohydrates reported 
typical for L. plantarum. DNA amplification yielded a fragment identical in size to that reported 
for L. plantarum. Strain AU02 did not produce gas from glucose, fermented the same sugars as E. 
faecium, and produced an amplicon characteristic for the genus Enterococcus. Strains PKT0003 
produced gas from the fermentation of glucose, displayed carbohydrate fermentation profiles 
similar to that of Leuconostoc spp, and DNA fragments identical in size to that reported for 
Leuconostoc lactis. The activity of bacteriocin Z1116 was detected after 3 h of growth. The 
activity of bacteriocins AU02 and PKT0003 was detected only after 9 h of growth. This 
corresponded to the early and middle stationary phase of growth, suggesting that the bacteriocins 
are secondary metabolites. Similar results were reported for bacteriocins HV219 and A.264 
produced by L. lactis subsp. lactis (Cheigh et al., 2002), and bacteriocin ST15 produced by E. 
faecalis (De Kwaadsteniet et al., 2005).  
There were similarities in the sizes of bacteriocins Z1116 (3.2 kDa), AU02 (10.0 kDa) and 
PKT0003 (10.0 kDa) with other bacteriocins produced by lactic acid bacteria. The sizes recorded 
for these bacteriocins are within the range reported for most bacteriocins produced by 
Lactobacillus spp and Enterococcus spp (De Vuyst and Vandamme, 1994).  Bacteriocins T196 
and DZ2 were 3.2 kDa and 6.5 kDa, respectively (Bello et al., 2016a,b). Bacteriocins JW3BZ, 
JW6BZ, JW11BZ and JW15BZ are between 2.3 and 3.3 kDa in size (Von Mollendorff et al., 
2006). Similar results were reported for bacteriocins ST194BZ (3.0 kDa and 14.0 kDa), 
ST242BZ (10.0 kDa), ST284BZ (3.5 kDa), ST414BZ (3.7 kDa), ST461BZ (2.8 kDa), ST462BZ 
(8.0 kDa), ST664BZ (6.5 kDa), ST712BZ (14.0 kDa) (Todorov and Dicks, 2006a). The 
properties of the three bacteriocins found in this study allow their characterization as group IIa 
bacteriocins produced by lactic acid bacteria, as they display similar properties in terms of 
molecular weight, heat and pH stability and sensitivity to proteolytic enzymes (Parente and 
Ricciardi, 1999; Verschuere et al., 2000; Cleveland et al., 2001; Cotter et al., 2005; Drider et al., 
2006; Gálvez et al., 2007; Mojgani and Amirinia, 2007; Todorov et al., 2010; Belguesmia et al., 
2011).  
The antimicrobial activity of the bacteriocins characterized in this study was affected by 
treatment of the cell-free supernatants with proteinase K, papain, pepsin and trypsin. No change 
in activity levels was recorded when the cell-free supernatants of strains Z1116 and AU02 were 
treated with α-amylase and catalase. Treatment of the cell-free supernatant containing bacteriocin 
PKT0003 with α-amylase resulted in loss of antibacterial activity. All three bacteriocins remained 
active after incubation at pH 2.0–8.0. Bacteriocin AU02 lost activity after treatment at pH 10.0. 
Treatment at pH 12.0 resulted in the loss of activity for strains AU02 and PKT0003. No decrease 
in antimicrobial activity was recorded after treatment of the cell-free supernatants at 25 30, 37, 45 
and 60
O




Surfactants such as SDS, Tween 20, Tween 80, urea and Triton X-100 had no effect on the 
activity of the three bacteriocins. Addition of Triton X-114 to bacteriocins Z1116 and AU02 led 




to decreased activity. Addition of 1.0, 2.0 or 5.0 mM EDTA to the bacteriocins did not affect 
their activity. Complete inactivation of the bacteriocins was observed after treatment of the cell-
free supernatants with proteolytic enzymes, confirming the proteinaceous nature of the 
antimicrobial compounds.  The sensitivity of bacteriocins PKT0003 to 100
O
C after 120 min and 
121
0
C after 20 min may be a result of their molecular mass (10.0 kDa), although the stability of 
bacteriocin AU02, a 10.0 kDa peptide was not affected by treatment for 120 min at 100
O
C. A 
difference in the structures of bacteriocin AU02 and PKT0003 may be a reason for these results. 
The Bozacin B.14 was inactivated after 10 min at 90–121
O
C (Ivanova et al., 2000). Not all 
bacteriocins are heat-stable. For certain bacteriocins (e.g. leucocin F10), pH influences 
temperature stability. Leucocin F10 is resistant to high temperatures at pH 3.0 and 5.0, but 
sensitive to the same temperatures at pH 7.0 and 9.0 (Parente et al., 1996).  
The mode of activity of bacteriocins Z1116, AU02 and PKT0003 is bactericidal. No growth 
was recorded when the bacteriocin-treated cells of E. faecium HKLHS and L. sakei DSM 20017 
were plated onto MRS agar. This agrees with the report of Von Mollendorff et al. (2006) on 
bacteriocins JW3BZ, JW6BZ, JW11BZ and JW15BZ, produced by L. plantarum  JW3BZ and 
JW6BZ and L. fermentum JW11BZ and JW15BZ, respectively, on inhibition of L. sakei DSM 
20017, implicating that these four bacteriocins had a bactericidal mode of action. Similar result 
was recorded for pentocin ST18 produced by P. pentosaceus ST18 (Todorov & Dicks, 2005c), 
mesentericin ST99 produced by L. mesenteroides subsp. dextranicum ST99 (Todorov & Dicks, 
2004), and the African fermented foods B.14 described for L. lactis subsp. lactis B.14 (Ivanova et 
al., 2000).  
The combined application of the sublethal levels of clinical antibiotic (rifampicin) and the 
three bacteriocins, antibacterial activity was strongly increased. Results showed significant 
inhibitions (P < 0.05) of the growth of L. monocytogenes NCTC 4885 when bacteriocin Z1116 at 
final concentrations of 160 AU ml
-1
, 80 AU ml
-1
, 40 AU ml
-1 
and 16 AU ml
-1
 were added to BHI 
medium with pH corrected to 7.0. Inhibition of growth of test organism was also observed at the 
introduction of only the clinical antibiotic (rifampicin) at final concentration of 0.2 µg ml
-1
 but 
this was not statistically significant (P > 0.05).  
Rifampicin at final concentrations of 0.1 µg ml
-1
 and 0.05 µg ml
-1
 showed very weak 
inhibition of growth, and thus, not statistically significant as compared with the control 
experiment. Rifampicin at final concentration of 0.2 µg ml
-1
 and bacteriocin Z1116 at 
concentration of 160 AU ml
-1
 exerted bactericidal effect on the test organism while this 
synergistic effect was also well established at lower concentrations of the antibiotic and 
bacteriocins.combined. These results indicate that the mechanism by which the cationic peptide 
increases the effectiveness of these antibiotics is through the dissipation of the proton gradient 
responsible for the extrusion of these compounds. This synergism between antibiotics, 
particularly rifampicin investigated in this study, and bacteriocins are important in order to 
reduce the level of the MIC of the antibiotics. Similar synergetic effects may be an important step 
in the future treatment of multidrug resistant strains. 
Inhibitions of growth exerted by rifampicin at all concentrations were not significantly 
different from the control (P > 0.05). There was, however, notable synergistic effect of this 
bacteriocin on the test organism when combined with different concentrations of the antibiotic. 
This difference was statistically significant (P < 0.05). Bacteriocin PKT0003 at concentration of 
160 AU ml
-1 
exerted visible antibacterial effect against L. monocytogenes NCTC 4885 and this 
was statistically significant (P < 0.05) as compared with control experiment. The synergistic 
relationship of bacteriocin PKT0003 and rifampicin at their different concentrations was also 
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well established as they were able to exert stronger antimicrobial effects on the test organism than 
when used unilaterally. 
In a similar study by Minahk et al. (2004), the effect of sub-lethal concentrations of 
enterocin CRL35, a cationic peptide, on the activity of erythromycin, chloramphenicol and 
tetracycline was studied. At studied sub-lethal concentrations, the peptide induces a significant 
membrane gradient dissipation without appreciable cell death. A plausible explanation is that 
membrane depolarization is necessary but not sufficient to produce cell death, and another 
concentration dependent step, not described at present may be implicated. It was reported that 
pleurocidin and its derivatives which are antimicrobial peptides from eukaryotic organisms lost 
their ability to damage cell membranes at sub-lethal concentrations, whilst maintaining their 
capacities to inhibit macromolecular synthesis (Patrzykat et al., 2002). 
The leakage of DNA, RNA, proteins and β-galactosidase confirmed that bacteriocins 
Z1116, AU02 and PKT0003 destabilized the permeability of the cell membrane. Similar results 
have been reported for buchnericin LB (Yildirim et al., 1999), plantaricin 423 (Todorov and 
Dicks, 2006b), pediocin AcH (Bhunia et al., 1991) and bacteriocin HV219 (Todorov et al., 
2007). Incubation of the producer cells in the presence of 100 mM NaCl at pH 2.0 did not result 
into detection of activity of bacteriocins AU02 and PKT0003, suggesting that these bacteriocins 
do not adsorb to cell-surfaces of the producer cells. Similar results were reported for bacteriocins 
ST194BZ, ST242BZ, ST284BZ, ST414BZ, ST461BZ, ST462BZ, ST664BZ and ST712BZ 
(Todorov & Dicks, 2006a).  
Von Mollendorff et al. (2006) reported a similar result that bacteriocins JW3BZ, JW11BZ 
and JW15BZ retained their activity after treatment with 100 mM NaCl at pH 2.0, indicating that 
bacteriocins JW3BZ, JW11BZ and JW15BZ adsorb to the cell-surface of the producer strains. 
This is in contrast with the result of Jillian (2006) who reported the adsorption of BacST8KF to 
sensitive and resistant strain of Gram-positive bacteria with percentage adsorption ranging from 
20% for Lb plantarum LMG 13556 to 80% for Lb casei LHS. The author suggested that the 
adsorption of BacST8KF to target strains does not confirm the activity of the peptide against the 
target strain. This was also buttressed by the report of Yildrim et al. (2002) where 100% 
adsorption of buhnericin LB to a strain of Pediococcus cerevisiae was insensitive. 
Some bacteriocins were found to adhere to the cell-surface of the producers such as 
pediocin AcH, nisin, sakacin A, leuconocin Lcm by Yang et al. (1992). In the case of plantaricin 
C19, produced by L. plantarum C19, maximal adsorption to the producer cells was recorded 
between pH 5.0 and 7.0, with a complete loss of adsorption at pH 1.5 and 2.0 (Atrih et al., 2001). 
This phenomenon may be used successfully in the purification of the bacteriocins.  
This study revealed that P. biglobosa is a rich source of bacteriocigenic LAB, and these 
bacteriocins and their biosynthetic mechanisms could be useful in food safety and security, 
preservation, peptide design, infection control and pharmacotherapy. This should help in the 
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